All Pharma News
price-trendAsk Us
Dabur Q1 FY25 consolidated net profit up 8% at Rs 500 Cr

Dabur Q1 FY25 consolidated net profit up 8% at Rs 500 Cr
INDIANPHARMAPOST
01 Aug 2024
Share Share
Dabur India updates on Q1 FY25

Dabur India updates on Q1 FY25
INDIAPHARMAPOST
06 Jul 2024
Share Share
India`s Religare asked to seek regulatory nod for top investor raising stake

India`s Religare asked to seek regulatory nod for top investor raising stake
REUTERS
19 Jun 2024
Share Share
Dabur India posts Q4 FY24 consolidated PAT at Rs. 349.53 Cr

Dabur India posts Q4 FY24 consolidated PAT at Rs. 349.53 Cr
INDINPHARMAPOST
04 May 2024
Share Share
Dabur India`s two units dismissed as defendants in hair relaxer lawsuit in US

Dabur India`s two units dismissed as defendants in hair relaxer lawsuit in US
REUTERS
15 Nov 2023
Share Share
Dabur India`s units face lawsuits in US, Canada alleging products caused cancer

Dabur India`s units face lawsuits in US, Canada alleging products caused cancer
REUTERS
19 Oct 2023
Share Share
Dabur India consolidated Q3FY23 PAT lower at Rs. 475.94 Cr

Dabur India consolidated Q3FY23 PAT lower at Rs. 475.94 Cr
INDIAN PHARMA POST
03 Feb 2023
Share Share